BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25512094)

  • 1. Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma.
    Zhao M; Zhang Y; Zhang H; Wang S; Zhang M; Chen X; Wang H; Zeng G; Chen X; Liu G; Zhou C
    Lung Cancer; 2015 Feb; 87(2):98-106. PubMed ID: 25512094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics.
    Satar NA; Fakiruddin KS; Lim MN; Mok PL; Zakaria N; Fakharuzi NA; Abd Rahman AZ; Zakaria Z; Yahaya BH; Baharuddin P
    Oncol Rep; 2018 Aug; 40(2):669-681. PubMed ID: 29845263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
    Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
    Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant features.
    Ni T; Wang H; Zhan D; Tao L; Lv M; Wang W; Chu Z; Zhou Z; Sunagawa M; Liu Y
    Life Sci; 2021 Mar; 269():119021. PubMed ID: 33450261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer.
    Ribeiro KB; da Silva Zanetti J; Ribeiro-Silva A; Rapatoni L; de Oliveira HF; da Cunha Tirapelli DP; Garcia SB; Feres O; da Rocha JJ; Peria FM
    Cancer Biomark; 2016 Mar; 16(4):513-21. PubMed ID: 27062566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma.
    Sowa T; Menju T; Sonobe M; Nakanishi T; Shikuma K; Imamura N; Motoyama H; Hijiya K; Aoyama A; Chen F; Sato T; Kobayashi M; Yoshizawa A; Haga H; Sozu T; Date H
    Cancer Med; 2015 Dec; 4(12):1853-62. PubMed ID: 26471868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].
    He J; Song X; Yu L; Li J; Qiao Z; Jiu R; Yu B; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):625-9. PubMed ID: 25940289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2.
    Bora-Singhal N; Mohankumar D; Saha B; Colin CM; Lee JY; Martin MW; Zheng X; Coppola D; Chellappan S
    Sci Rep; 2020 Mar; 10(1):4722. PubMed ID: 32170113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma.
    Xiao ZJ; Liu J; Wang SQ; Zhu Y; Gao XY; Tin VP; Qin J; Wang JW; Wong MP
    Elife; 2017 Jul; 6():. PubMed ID: 28737489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
    Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
    Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms.
    Ye MX; Zhao YL; Li Y; Miao Q; Li ZK; Ren XL; Song LQ; Yin H; Zhang J
    Phytomedicine; 2012 Jun; 19(8-9):779-87. PubMed ID: 22483553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
    Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
    J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop.
    Shi L; Wang Y; Lu Z; Zhang H; Zhuang N; Wang B; Song Z; Chen G; Huang C; Xu D; Zhang Y; Zhang W; Gao Y
    Oncogene; 2017 Mar; 36(12):1631-1643. PubMed ID: 27869168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LETM1 is a potential cancer stem-like cell marker and predicts poor prognosis in colorectal adenocarcinoma.
    Piao L; Feng Y; Yang Z; Qi W; Li H; Han H; Xuan Y
    Pathol Res Pract; 2019 Jul; 215(7):152437. PubMed ID: 31101574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?
    Tachezy M; Zander H; Wolters-Eisfeld G; Müller J; Wicklein D; Gebauer F; Izbicki JR; Bockhorn M
    Stem Cells; 2014 Jun; 32(6):1429-36. PubMed ID: 24501004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
    Su J; Wu S; Tang W; Qian H; Zhou H; Guo T
    Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.